Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mario Santinami
Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation Alone in Resected Stage III Melanoma: Final Results of EORTC 18991, a Randomised Phase III Trial
The Lancet
Medicine
Related publications
Us Burden of Illness Associated With Adjuvant Therapy for Stage I-Iii Melanoma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Safety of UFT/LV and S-1 as Adjuvant Therapy for Stage III Colon Cancer in Phase III Trial: ACTS-CC Trial
British Journal of Cancer
Cancer Research
Oncology
Perioperative Haemostasis With Full‐length, PEGylated, Recombinant Factor VIII With Extended Half‐life (Rurioctocog Alfa Pegol) in Patients With Haemophilia A: Final Results of a Multicentre, Single‐arm Phase III Trial
Haemophilia
Medicine
Genetics
Hematology
Interim Analysis of Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin Versus Capecitabine Alone for Pathological Stage II and III Rectal Cancer: A Randomized Multicenter Phase III Trial
Oncotarget
Oncology
P-0218 * Timing and Regimens of Adjuvant Therapy for Resected Stage Ii and Iii Colon Cancer
Annals of Oncology
Medicine
Oncology
Hematology
Prm21 - Modelling Survival of Patients With Completely Resected Advanced Melanoma With Adjuvant Treatment of Nivolumab Versus Observation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Association Between Circulating Tumor Cells and Prognosis in Patients With Stage III Melanoma With Sentinel Lymph Node Metastasis in a Phase III International Multicenter Trial
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Prostate Cancer and Hypofractionation: Reflections on Recent Randomised Phase III Clinical Trial Results
Translational Andrology and Urology
Reproductive Medicine
Urology
Randomized Phase III Trial Comparing Surgery Alone to UFT + PSK for Stage II Rectal Cancer (JFMC38 Trial)
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
